CD8A and neoplasm: To circumvent problems posed by CAR T cells, we propose that perhaps the most effective strategy to control solid tumor growth is one that does not require identifying TAAs and corresponding tumor-reactive CD8+ T cells, can enhance effector activity of CD8+ T cells, and can simultaneously eliminate immune suppression within the TME.